Analysis GlaxoSmithKline PLC (NYSE:GSK)‚ formed through the merger of British drug makers Glaxo Wellcome and SmithKline Beecham in December 2000‚ ranks as the world’s second largest pharmaceutical company. GSK group engaged in the creation‚ discovery‚ development‚ manufacture and marketing of pharmaceutical and consumer health-related products. GlaxoSmithKline supply one quarter of the world ’s vaccines and by the end of February 2008 GSK had 24 vaccines in clinical development. It has operations
Premium Pharmaceutical industry
GlaxoSmithKline (GSK) is one of the largest and most profitable pharmaceutical companies in the world. This conglomerate is the product of multiple mergers of some of the leading companies in the industry. It was created in 2000 and at the time this case was written‚ had a market capitalization of $193.5 billion. The company’s most recent focus is on emerging markets‚ vaccines and consumer healthcare. When Sir Andrew Witty took over as CEO in 2008‚ he implemented a significant restructuring program
Premium Vaccine Pharmacology Pharmaceutical industry
EC229 Economics of Strategy Introduction 1. GlaxoSmithKline (GSK) is a global healthcare company specialized in the research‚ development‚ manufacturing and marketing of pharmaceutical and consumer health-related products. The company has operations in 120 countries‚ with products being sold in over 150 countries. (Description) 2. As a dominant player in the pharmaceutical industry‚ GSK operates in an oligopolistic market. It is highly cash generative‚ with increased sales growth and shareholder
Premium Costs Economics Oligopoly
POST MERGERS HR AND CULTURAL ISSUES The post liberalization period was of mergers and acquisitions and still it is continuing as a strategic driver for market dominance‚ geographical expansion‚ leverage in resource and capability acquisition‚ competence‚ adjusting to competition. M&As are strategic alliances. People Management plays a critical role in M&A. People [pic]issues like staffing decision‚ organizational design‚ etc.‚ are most sensitive [pic]issues in case of M&A negotiations‚ but it
Premium Mergers and acquisitions Organizational culture Culture
DaimlerChrysler Post-Merger Integration The case ‘The ‘DaimlerChryler Post-Merger Integration’ gives an overview of the merger between DaimlerBenz AG of Germany and Chrysler Corporation of the US. The case focuses on the post-merger integration and the various problems faced by the merged entity. It also explores the enormous cultural differences and management styles and the problems to realize the synergies identified prior to the merger. Why did they decide to merge? At the time of the merger both
Premium Daimler AG Decision making Management
important that we generate more growth with less risk." GSK needs to find new sources of growth at a time when governments around the world are reforming healthcare and cutting spending. It is also outsourcing more research to partners to reduce risk. Its long-running collaboration with the US company‚ Theravance which is responsible for one of GSK ’s most promising new drugs‚ the asthma treatment Relovair‚ which is now in late-stage development. GSK recently upped its stake in Theravance to 19% and this
Premium Clinical trial Strategic management Pharmacology
Introduction Based on a report conducted by a pharmaceutical magazine‚ Glaxosmithkline plc (Also known as GSK) is the fifth largest pharmaceutical company around the world (Contract Pharma‚ 2013). And it is also tided at No.112 on the 2013 ’s Global 2000 list‚ the list that manifests the 2000 most enormous companies in the world (Forbes‚ 2013). The researches above have indicated that GSK is one of the largest Transnational Corporation in the world. Top 10 Pharmaceutical Companies based on 2012
Premium Strategic management Pharmaceutical industry
CASE STUDY Presentation Outline: Background Case Summary What is ‘crisis management’? Strategic Phase Reactive Phase Image Restoration Lessons Learnt Background: GlaxoSmithKline (GSK) is a British multinational pharmaceutical and consumer healthcare company that operates in over 100 countries. They have an extensive portfolio of products for major disease areas including asthma‚ cancer‚ infection‚ diabetes and digestive conditions Some products they produce that you might be familiar
Free Crisis management Management
Every coin has two sides. After the merger‚ both companies encountered several problems during their integration. Next‚ I will go into details about issues they faced. First of all‚ they wanted to further solidify their brand presence. Fiat has been successful in the European market but lacks visibility in North America; while Chrysler does not carry a strong dealer network in the European markets. What’s worse‚ historically‚ Chrysler was referred to the “Number Three” auto manufacturer and even
Premium General Motors
GSK Marketing Planning | March 31 2013 | Calvin Cheung‚ Hussain Al Katib‚ Manpreet Budwal‚ Sandra Okechukwu | SOSTAC Review based on GlaxoSmithKline | Content Table of Contents 1.0 Introduction2 2.0 Situation Analysis3 2.1 PESTEL Analysis3 2.2 SWOT Analysis4 2.3 Boston Matrix5 2.4 Porter’s Five Forces Analysis6 3.0 Objectives8 4.0 Strategy9 4.1 Product9 4.2 Price9 4.3 Promotion9 4.4 Place10 4.5 Person10 4.6 Process10 4.7 Physical Evidence10 5.0 Tactics11 6.0 Action Plan12
Premium Marketing